Molecular Assays for Characterization of Alternatively Spliced Isoforms of the Mu Opioid Receptor (MOR)
Authors:
Open Access
- 13 February 2010
- book chapter
- Published by Springer Nature
- Vol. 617, 421-435
Abstract
Mu-opioid receptor (MOR) belongs to a family of heptahelical G-protein-coupled receptors (GPCRs). Studies in humans and rodents demonstrated that the OPRM1 gene coding for MOR undergoes extensive alternative splicing afforded by the genetic complexity of OPRM1. Evidence from rodent studies also demonstrates an important role of these alternatively spliced forms in mediating opiate analgesia via their differential signaling properties. MOR signaling is predominantly Gia coupled. Release of the α subunit from G-protein complex results in the inhibition of adenylyl cyclase/cAMP pathway, whereas release of the βγ subunits activates G-protein-activated inwardly rectifying potassium channels and inhibits voltage-dependent calcium channels. These molecular events result in the suppression of cellular activities that diminish pain sensations. Recently, a new isoform of OPRM1, MOR3, has been identified that shows an increase in the production of nitric oxide (NO) upon stimulation with morphine. Hence, there is a need to describe molecular techniques that enable the functional characterization of MOR isoforms. In this review, we describe the methodologies used to assay key mediators of MOR activation including cellular assays for cAMP, free Ca2+, and NO, all of which have been implicated in the pharmacological effects of MOR agonists.Keywords
This publication has 40 references indexed in Scilit:
- Expansion of the human μ-opioid receptor gene architecture: novel functional variantsHuman Molecular Genetics, 2008
- Rapid, Opioid-sensitive Mechanisms Involved in Transient Receptor Potential Vanilloid 1 SensitizationJournal of Biological Chemistry, 2008
- Concentration‐effect and dose‐response relations in clinical pharmacologyBritish Journal of Clinical Pharmacology, 2007
- Integrins regulate opioid receptor signaling in trigeminal ganglion neuronsNeuroscience, 2007
- Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liabilityPain, 2000
- Pain: Molecular mechanismsThe Journal of Pain, 2000
- Dissociation between the Inhibitory and Stimulatory Effects of Opioid Peptides on cAMP Formation in SK-N-SH Neuroblastoma CellsBiochemical and Biophysical Research Communications, 1998
- The stimulatory effect of opioids on cyclic AMP production in SK-N-SH cells is mediated by calcium ionsLife Sciences, 1997
- Altered μ‐Opiate Receptor‐G Protein Signal Transduction Following Chronic Morphine ExposureJournal of Neurochemistry, 1997
- Brain and caudate nucleus adenylate cyclase: Effects of dopamine, GTP, E prostaglandins and morphineFEBS Letters, 1975